2020
DOI: 10.1101/2020.07.20.213108
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Severe perinatal hydrops fetalis in genome edited pigs with a biallelic five base pair deletion of the Marfan syndrome gene, FBN1

Abstract: This paper describes a genome editing project using CRISPR-Cas9. The objective was to create a large animal model of human Marfan syndrome by targeting the FBN1 gene of the pig, Sus scrofa, using a single guide and non-homologous end joining which was expected to create short insertion or deletion mutations at the 5’ end of the gene. The editing successfully created a five base pair deletion in exon 2 of FBN1, which was homozygous in two animals. However, the phenotype of these piglets was unexpected, since th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 55 publications
0
1
0
Order By: Relevance
“…FBN1 variants have been introduced in the pig using genome editing. Our own attempt using CRISPR-Cas9 genome editing to target exon 2 of the pig FBN1 resulted in 2 offspring with an identical homozygous 5-base pair deletion ( Tsang et al 2020 ). The piglets were severely compromised by hydrops fetalis, a complication not reported for MFS or the homozygous mouse models, and likely the result of off-target effects.…”
Section: Fibrillin-1 and Marfan Syndromementioning
confidence: 99%
“…FBN1 variants have been introduced in the pig using genome editing. Our own attempt using CRISPR-Cas9 genome editing to target exon 2 of the pig FBN1 resulted in 2 offspring with an identical homozygous 5-base pair deletion ( Tsang et al 2020 ). The piglets were severely compromised by hydrops fetalis, a complication not reported for MFS or the homozygous mouse models, and likely the result of off-target effects.…”
Section: Fibrillin-1 and Marfan Syndromementioning
confidence: 99%